Health Care/Hospital

Everest Medicines Announces Commercial Launch and First Prescription for XERAVA® in China

Everest transforms into a commercial-stage innovative biopharmaceutical company SHANGHAI, July 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicin...

2023-07-27 08:10 1745

YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023

Total revenues increase by 36.3% year-over-year; gross margin improves to 77.7%; balance sheet remains robust Company's PIKA rabies vaccine approved for Phase III clinical trials in Singapore, the Philippines, and Pakistan; interim results expected early next year GAITHERSBURG, Md., July 27, 20...

2023-07-27 05:00 4112

Hummingbird Bioscience Initiates HMBD-001 Phase IB Trials in Australia and Partners with Omico to Accelerate Clinical Development

* Hummingbird Bioscience has initiated two clinical trials in Australia evaluating HMBD-001 in patients with squamous non-small cell lung cancer and patients with genetic aberrations in HER3 signaling * Hummingbird Bioscience has identified genetic signatures that are predictive of response t...

2023-07-27 04:00 1680

CartiHeal Announces First Commercial Implantation of Agili-C™ in the US

KFAR SABA, Israel, July 26, 2023 /PRNewswire/ -- CartiHeal Ltd. , developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today announced its first commercial implantation of Agili-C in the US by Dr. Ken...

2023-07-26 21:04 1512

PharmAbcine Announces First Patient Dosed in the Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD

DAEJEON, South Korea, July 26, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the first patient has been dosed in the Phase I clinical trial of PMC-403, the Compa...

2023-07-26 20:00 1309

How MGI Boosts Agrigenomics and Food Sustainability with Sequencing Technology: An Australian Case Study

PERTH, Australia, July 26, 2023 /PRNewswire/ -- In the wake of the recent UN Food Systems +2 Stocktaking Moment in Rome, the spotlight on global food security has never been more critical. Addressing the challenges of a burgeoning population and changing climate requires innovative solutions, and...

2023-07-26 19:18 1655

Philips Future Health Index 2023 Report: APAC's healthcare sector embracing new care delivery model to tackle financial pressures and staff shortages

* Largest global survey of its kind finds investment in smart and connected digital health technologies and expansion of virtual care towards new models of care are top priorities for the region. * Healthcare professionals in APAC are counting on new care delivery models to enable better pati...

2023-07-26 16:05 1821

Samsung Biologics Reports Second Quarter 2023 Financial Results

* Recorded Q2'23 consolidated revenue of KRW 866.2 billion * Recorded Q2'23 consolidated operating profit of KRW 253.4 billion * Achieved record-high semi-annual revenue exceeding KRW 1,587.1 billion * Strong growth sustained with successful contract wins and full completion of Plant 4 set ...

2023-07-26 15:23 1494

World's first*1 report: A potential effectiveness of Plasmacluster Technology that may induce brain activation

Validation of the mechanism of its enhancing effect on human work performance by measuring brain function *2 OSAKA, Japan, July 26, 2023 /PRNewswire/ -- Sharp Corporation conducted collaborative research on its Plasmacluster technology, with Dr.Goichi Hagiwara , Associate Professor, Faculty of Hu...

2023-07-26 14:15 1587

Lunit Accelerates Expansion Across Middle East by Bringing AI Solution to Dr. Sulaiman Al Habib Medical Group, Middle East's Largest Healthcare Provider

Lunit strengthens presence in the Middle East by supplying AI-powered breast screening solution to Dr. Sulaiman Al Habib Medical Group for the next three years SEOUL, South Korea, July 26, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnosti...

2023-07-26 14:00 1309

China's Yunhong Group furthers global push on full biodegradation

WUXUE, China, July 26, 2023 /PRNewswire/ -- Recently, the economic representative office ofGuinea-Bissau was unveiled in the pan-health industrial park of Yunhong Group in Wuxue City in centralChina's Hubei Province. The company and representatives of African countries reached a series of cooper...

2023-07-26 13:07 1435

Cariflex Relocates Headquarters In Singapore In The Run-Up To The Start Of Production At Its World Scale Polyisoprene Latex Plant In 2024

* The new manufacturing site will bring an additional 80 permanent jobs in engineering, production, quality, supply chain, and other manufacturing support functions SINGAPORE, July 26, 2023 /PRNewswire/ -- The global market leader in polyisoprene rubber latex for medical-end markets, Cariflex P...

2023-07-26 09:00 2510

Mabwell to Present Clinical Trial Data of 2 Programs at ESMO Congress 2023

SHANGHAI, July 25, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that clinical trial data from phase I/II study for advanced solid tumor of Nectin-4-targeting ADC (9MW2821), and phase III study of Long-Acting Recombinant Hu...

2023-07-26 00:00 1668

Alma, a Sisram Medical Company, Announces the Launch of Alma Veil™ for the U.S. Market

HONG KONG and CHICAGO, July 25, 2023 /PRNewswire/ -- Alma, a global leader in the energy-based medical and aesthetic solutions industry, proudly announces the commercial availability of Alma Veil™. This advanced, dual-wavelength vascular laser workstation establishes a new standard in excellence ...

2023-07-25 22:10 1608

Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships advance the next generation of leaders

NEW YORK, and PARIS, July 25, 2023 /PRNewswire/ -- The Pasteur Foundation US and theInstitut Pasteur are pleased to announce that the 2023 cohort of Lady Mireille and Sir Dennis Gillings Global Public Health Fellowships have been conferred. Those excelling in science will have a rare opportunity ...

2023-07-25 21:00 1613

Fapon Launches the Most Efficient Chemiluminescence Immunoassay Analyzer to Date with Throughput of 900 T/h

ANAHEIM, Calif., July 25, 2023 /PRNewswire/ -- Fapon, a global leading life sciences company, has announced the launch of its latest chemiluminescence immunoassay system Shine i8000/9000 to global markets at the 2023 AACC exhibition. The high-speed and fully automated analyzer has an ultra-high ...

2023-07-25 20:07 1377

HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement

* HaemaLogiX and Peter MacCallum Cancer Centre have entered a collaboration agreement to develop and conduct the first Phase I human trial of HaemaLogiX's CAR-T cell therapy in patients with kappa-type myeloma * The agreement is the culmination of previous preclinical research collaboration b...

2023-07-25 19:30 992

RemeGen's Telitacicept Shows Significant Promise in Phase II Trial for Primary Sjogren's Syndrome: Findings Published in Prestigious Rheumatology Journal

YANTAI, China, July 25, 2023 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated commercial-stage biotechnology company, has announced that their Phase II clinical study of telitacicept (RC18) for the treatment of ...

2023-07-25 16:00 1497

Foresee Pharmaceuticals Selected for Late-Breaking Oral Presentation on its Aderamastat Phase 2 Study Results at the European Respiratory Society (ERS) International Congress 2023

TAIPEI, July 25, 2023 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced today that the company has been selected for a late-breaking oral presentation on the positive primary outcomes of its aderamastat (FP-025) Phase 2 proof-of-concept allergic asthma study at the Euro...

2023-07-25 15:19 1580

Duopharma Biotech Applauded by Frost & Sullivan for Providing Innovative Healthcare Solutions in the Malaysian Market

Duopharma Biotech is a worldwide pioneer in the research and development of halal pharmaceuticals. SAN ANTONIO, July 25, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the Malaysian halal pharmaceutical industry and, based on its findings, recognizesDuopharma Biotech Berhad (Duopharma...

2023-07-25 14:00 1452
1 ... 107108109110111112113 ... 802